Approximately 118,116 units of Thyroxine L and Thyroxyl (levothyroxine sodium) tablets and oral solutions for veterinary use are being recalled. These medications, used to treat thyroid conditions in animals, were manufactured using processing and cleaning procedures that were not properly validated, alongside other quality system failures. This means the manufacturer cannot guarantee the potency, purity, or safety of the drugs, which could lead to ineffective treatment or unexpected side effects for pets.
The lack of validated cleaning and production procedures creates a risk of cross-contamination between different drug products or incorrect dosing levels. If a pet receives a product with inconsistent active ingredients or contaminants, their thyroid condition may not be properly managed, potentially leading to serious health complications.
Contact healthcare provider and return product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response